Rhumbline Advisers Bionano Genomics, Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.57 - $1.16 $257,018 - $523,055	-450,910 Reduced 93.95%	29,058 $17,000
Q1 2023 May 11, 2023	BUY	$1.06 - $1.97 $18,681 - $34,719	17,624 Added 3.81%	479,968 $533,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $25.4 $8,827 - $160,147	6,305 Added 1.38%	462,344 $675,000
Q3 2022 Nov 10, 2022	BUY	$0.36 - $36.0 $13,225 - $1.32 Million	36,737 Added 8.76%	456,039 $835,000
Q2 2022 Aug 11, 2022	BUY	$12.3 - $27.3 $1.46 Million - $3.24 Million	118,738 Added 39.51%	419,302 $579,000
Q1 2022 May 12, 2022	BUY	$16.6 - $32.3 $108,796 - $211,694	6,554 Added 2.23%	300,564 $775,000
Q4 2021 Feb 10, 2022	SELL	$29.9 - $61.2 $73,853 - $151,164	-2,470 Reduced 0.83%	294,010 $879,000
Q3 2021 Nov 12, 2021	BUY	$51.4 - $68.2 $370,234 - $491,244	7,203 Added 2.49%	296,480 $1.63 Million
Q2 2021 Aug 05, 2021	BUY	$44.1 - $84.0 $12.8 Million - $24.3 Million	289,277 New	289,277 $2.12 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.